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ABSTRACT 
 
Aims: To determine the level of agreement between the visual Fields easy application (VFE) for 
iPad and a standard clinical test for assessing peripheral vision in stroke survivors. 
Study Design: This was a prospective cross-sectional study comparing the VFE application to the 
Humphrey Field Analyser (HFA) SITA Fast c30-2 program in identifying and diagnosing visual field 
defects post-stroke.  
Place and Duration of Study: The ophthalmic department at Imperial College Healthcare NHS 
Trust. Data collection was undertaken between January 2016 and August 2016. 
Methodology: A total of 50 participants with a diagnosis of stroke and a suspected visual problem 
were recruited to the study. Normative data was collected from 50 participants with no history of 
stroke or visual loss. Analysis comprised of comparing the extent of the visual field loss detected by 
both the VFE and HFA, and clinically assessing the results for normality. 
Results: Bland-Altman analysis demonstrated that with more severe visual field loss, the agreement 
between both modalities was found to decrease. There was a higher proportion of false negatives 
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with the VFE compared to the HVF. The bias towards detecting more missed test locations with the 
VFE application compared to the HFA was 6% for the normal participants and 2% for the stroke 
participants. The limits of agreement between the two modalities were large; 20% and 40% for the 
normal and stroke participants respectively. The sensitivity of the VFE application to determine an 
abnormal visual field in comparison to HFA was 88% and specificity was 76% in the stroke cohort 
based upon a clinical impression of its findings. The majority of stroke participants (88%) found the 
VFE test more comfortable to perform. 
Conclusion: As a screening tool, the VFE application is quick and easy to administer, preferred by 
patients and has good sensitivity and specificity for detecting the presence of an abnormal visual 
field when compared to HFA. In patients with extensive visual field loss, the VFE may overestimate 
visual field reduction.  
 
 
Keywords: Stroke; applications; field loss; iPad. 
 
1. INTRODUCTION  
 
Stroke is a common condition in the United 
Kingdom, estimated to occur in approximately 
152,000 people per annum [1] and is a leading 
cause of adult disability [2]. Any visual 
dysfunction following stroke can affect the overall 
rehabilitation of the patient and their overall 
quality of life [3–6]. Approximately 60% of 
patients suffer visual impairment immediately 
post-stroke [3,7,8]. If correctly identified, patients 
with visual field loss after stroke may be eligible 
for treatments to help with restitution of the visual 
field or use of compensatory strategies [9].  
 
A reduction in the visual field is observed in 8-
67% of stroke survivors, but this may also be 
related to previous strokes or ocular pathology 
[3,5,10–13]. The wide variation in the cited 
incidence of visual field defects could be related 
to the timing of the visual field assessment [14], 
and the limitations of bedside visual field testing, 
including its subjective nature, inter-observer 
variability, and variations in methodology and 
documentation [15]. The diagnostic accuracy of 
referrals by the multidisciplinary stroke team is 
lower when there are no visible ocular ‘signs’ of 
dysfunction such as with visual field loss [16]. It 
is also acknowledged that many stroke patients 
are not referred for a visual assessment, as a 
problem is not suspected. Indeed 10% of stroke 
patients with a visual field defect are not 
subjectively aware of a problem [3]. 
 
Automated visual field assessment with static 
testing strategies, such as those employed by 
the Humphrey Visual Field analyser, (The HFA II-
I, Humphrey Instruments, Dublin, CA), are 
extensively used to identify field abnormalities in 
neurologic diseases [17,18]. However, to comply 
with formal testing, patients are required to have 
sufficient mobility, be able to sit upright at the 
perimeter, and sufficient cognition to concentrate 
for approximately 20 minutes. Should a patient 
not be able to concentrate or manoeuvre to 
perform a Humphrey visual field assessment, the 
confrontation visual field assessment is often the 
only viable alternative.  
 
The confrontation method of visual field 
assessments is a gross, qualitative method, 
whereby a clinician will ask the participant to 
cover one eye and identify a hand or finger in the 
periphery while concentrating on a point, usually 
the clinicians eye. Notable advantages are that it 
does not require any special equipment and is 
therefore inexpensive and available to 
underdeveloped settings worldwide. It can also 
be performed in a variety of environments 
including a non-upright patient position. The test 
is quick to perform, and maintains direct 
interaction with the patient, making the 
assessment less intimidating [19]. However, the 
confrontation test is less than ideal for several 
reasons. It is not a standardised procedure and 
several variations of the method exist [20]. There 
is significant inter-examiner variation in 
technique, sensitivity and documentation [21,22]. 
It requires a skilled and experienced professional 
to administer and evaluate the test and is 
therefore costly in terms of clinician time. Even 
then only gross visual field defects are detected 
[19]. 
 
The limitations of the confrontation method and 
subsequent attempts at developing alternative 
strategies demonstrate the need for a 
quantitative, simple, fast, accurate and portable 
method of visual field testing, suitable for those 
with impaired mobility and concentration. The 
development of smartphone and tablet based 
technologies, such as the Apple iPad (iPad 
model 2, by Apple Inc, USA.), and their use in 
healthcare and research has become more 
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widespread [23]. Applications have been 
developed to examine the visual field on tablet 
computers. In order to evaluate the usefulness of 
such applications in stroke patients and controls, 
the visualFields easy application has been 
selected for investigation, to establish its 
sensitivity to detect visual field defects in the 
stroke population. 
 
2. METHODOLOGY  
 
This was a prospective cross-sectional study 
comparing the visualFields easy app to the HFA 
SITA Fast c30-2 program in identifying and 
diagnosing visual field defects post-stroke. All 
stroke survivors referred to the Visual Field 
Service at Imperial College Healthcare NHS 
Trust who met the study criteria were offered 
inclusion. 
 
The target population comprised of a census of 
patients with any undifferentiated visual difficulty 
following a stroke. Referrals were made from 
inpatient wards, rehabilitation units, and 
community service or outpatient stroke and 
ophthalmology clinics. Participants were 
excluded if they were under 18 years, had only 
suffered a transient ischaemic attack or had a 
history of self-reported visual field loss prior to 
the stroke. All participants had a visual acuity of 
6/60 Snellen or better in either eye. 
 
Normative data were collected from an equal 
number of healthy volunteers who were recruited 
from hospital staff, students and volunteers. They 
were required to meet the same inclusion criteria 
as the stroke survivors, and all of them had no 
history of stroke. 
 
All participants provided full written consent 
before participation in the study. Block 
randomisation was used as to which modality 
and which eye was tested first, to help reduce 
the effects of fatigue and any learning effect seen 
in visual field assessment [24]. The right eye was 
primarily used for analysis but a repeat analysis 
was also performed on data from the left eye, to 
check for consistency.  
 
2.1 Instruments 
 
Visual field assessments were performed using 
the HFA SITA Fast c30-2 program on the 
Humphrey Field Analyser (HFA) II- model and 
the visualFields easy app (VFE) on an iPad. The 
hardware used was the iPad model 2 developed 
by Apple Inc., USA. The software was the 
visualFields easy application version 8.0 
developed by George Kong Softwares. Although 
every effort was made to ensure test conditions 
were as similar as possible between tests, such 
as the ambient room lighting there were technical 
differences between the two tests. A summary of 
the technical specifications and differences 
between the modalities is provided (Table 1). 
 
Instructions of the testing process were included 
on the participant information sheet; this was 
supplemented with detailed verbal instructions on 
how to perform a visual field test during the 
assessment. Participants completed the 
demonstration programme of both modalities, 
which acted as a brief practice of the test 
procedure. Assessment with the HFA perimeter 
was performed as per manufacturer guidelines 
[25]. Participants sat upright at the perimeter with 
head positioned against a bar and chin rest and 
eye aligned with the central point. Each eye was 
assessed as per block randomisation whilst the 
other eye was occluded with a patch. Corrective 
lenses were used according to their age and 
known refractive error. Stroke participants held 
the buzzer with their strongest hand at the time 
of testing and the dominant hand was used in the 
control group. Participants used the same hand 
to press the buzzer or tap iPad screen in both 
tests. The principal investigator observed the 
accuracy of the test by monitoring fixation losses 
and false negatives. Patients were given 
reminder prompts as to the test instructions when 
fixation losses occurred. The procedure was then 
repeated with the alternate eye. A minimum of 1-
minute rest was allowed between testing each 
eye to help minimise error from fatigue. There 
was no on demand pause facility available for the 
VFE test, however a pause was possible before 
the machine moved from testing one quadrant of 
the visual field to the next.  
 
For the VFE application, manufacturer 
instructions were brief (Fig. 1), but perimetry was 
undertaken with the following considerations. 
The participant sat with the iPad held at 33 cm 
and wore their own glasses for this test if they 
had a pair. The iPad was supported by a height 
adjustable table, but the examiner also supported 
the iPad with a hand to prevent it falling or being 
pushed further back by the participant. The 
examiner observed the head position of the 
participant to ensure the correct head position 
remained as close as possible to the 33 cm 
required distance. The participant was required 
to focus on a red fixation target, which was 
placed in one corner of the iPad screen and tap 
on the screen every time the white st
was shown, each quadrant of the visual field was 
 
Table 1. Technical specifications of hardware and software for the visual
application and Humphrey Visual Field Analyze
 V
Number of locations tested 96
Background luminance 31.5 apostilb
Ambient lighting Dimmed in clinic room + iPad
screen fixed at default setting
Fixation target Corner of display
Programme Threshold Suprathreshold
Stimulus Size (cf Goldmann) Goldmann size V
Stimulus Luminosity (decibels) 16 dB
Pace (seconds) Stimulus display 1s, 
delay 0.4s
Static/Kinetic Static
Test distance (cm) Free space at 33
Test area (degrees) 30° horizontal; 
24° vertical
Refractive correction Own lenses
 
Fig. 1. Screen captures from the VFE application interface pages. Image [A] Sample copy of 
visual field report graphic for a right eye assessment. Image [B] Application title page. Image 
[C] User interface for patient details and test selection. Image [D] Patient
to testing
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imulus light tested sequentially. The examiner manually
observed fixation to ensure the eye remained
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still. However, observing patient’s fixation was 
difficult without the aid of an internal camera or 
telescope as with other perimeters. Information 
on false positive and negative responses was not 
available during the test and could only be 
examined after the test had finished. A minimum 
of one minute’s rest was given between 
assessments. A record of the duration of the VFE 
test was performed manually by the principal 
investigator as the application did not provide this 
data. 
 
2.2 Visual Field Status 
 
The visualFields easy app provides raw data on 
the number of unseen test points, in addition to 
false positive and negative responses, allowing 
for an assessment of field validity.  
 
This was compared directly to the age and 
sensitivity-adjusted decibel data of the pattern 
deviation map provided by the HFA; a test point 
was considered “missed” if it deviated by p <1% 
[26]. 
 
Due to the different number of test locations 
between the modalities, a percentage of missed 
test stimuli on the application was compared to 
the percentage of missed test stimuli on the    
HFA. Statistical agreement between the 
measures was assessed using the Bland-Altman 
technique [27].  
 
The ability of the application to detect a normal or 
abnormal visual field was compared to the 
results from the HFA SITA Fast c30-2. The HFA 
would classify visual fields as normal, abnormal 
or borderline. The assessment of normality for 
the VFE was made by the principal investigator 
based upon clinical impression in a later review 
of all the VFE results. The investigator was 
blinded to the results of participant identity and 
the results of the HFA, when assessing the visual 
field for normality. Sensitivity, specificity, positive 
and negative predictive values were then 
calculated with Fisher's exact test using 
Graphpad Prism V6 for Mac, USA.  
 
All of the required assessments were completed 
within a 24-hour period and the majority were 
completed within one patient encounter, to 
minimise any effect of changes within the visual 
field. The year of stroke incidence ranged from 
1988 to 2016, this was skewed as several 
patients were referred to the department a 
number of years after their stroke. A clear 
majority of participants (86%) experienced              
their stroke during the recruitment period of the 
study.  
 
2.3 Qualitative Feedback 
 
Following the assessment of both visual field 
tests participants were asked the following 
closed questions: 
 
1. With which test did you find it easier to 
keep your eyes still? 
2. Which test felt the most comfortable to 
perform? 
3. Would you be interested in testing your 
own visual field with an application at 
home? 
 
2.4 Sample Size Justification 
 
As recommended by Bland [3] a total of 100 
participants were recruited to this study for 
Bland-Altman analysis, comprising 50 stroke 
participants and 50 from normative group who 
were analysed as separate groups and in a 
combined data plot. 
 
2.5 Ethical Approval 
 
This Study was approved by Stanmore Research 
Ethics Committee (Reference16/LO/0102) and 
Imperial College Healthcare NHS Trust. 
 
3. RESULTS AND DISCUSSION 
 
3.1 Background Results 
 
Overall 62 patients were referred to the Orthoptic 
and Visual Field Service for assessment during 
the recruitment period of this study. Of those not 
recruited, reasons included: declined to be 
involved as felt unwell (n=3), transferred/ 
discharged before enrolment commenced (n=4), 
known history of previous visual field loss (n=4). 
A total of 51 patients were recruited into the 
study, one patient was able to complete the iPad 
assessment but not able to sit at the HFA and 
was excluded at that point. Of the patients 
recruited from the stroke population 70% were 
male (n= 35) and 30% female (n=15). The mean 
age was 62 years (range 27-88: SD 17 years). A 
total of 50 healthy participants were recruited to 
generate normative data, 64% were female ,due 
to a higher proportion of female staff and 
students at the hospital (n=32) and 36% male 
(n=18). The mean age of the normative group 
was 46 years (range 20-91: SD 19 years). 
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3.2 Comparing the Extent of Visual Field 
Loss 
 
The extent of visual field loss was assessed by 
totalling the number of unseen test points from 
each modality. This was then expressed as a 
percentage as the number of test locations 
varied between modalities, with 76 test point 
locations for the HFA C30-2 program and 96 for 
VFE. A paired t-test was performed on the data 
collected from the HFA and VFE for both stroke 
and normal groups with right and left eyes. The t-
test was used to investigate any significant 
difference between the extent of visual field loss 
detected between the two tests. 
  
In the control group the HFA demonstrated 
statically fewer missed test points than the VFE, 
assessed by a paired t-test in the right eye, t (49) 
= 5.7, P= <.005 and left eye t (49) = 4.9, P= 
<.005, data sets. However, for the stroke 
population the paired t-test showed no 
statistically significant difference in the number of 
missed test points, between the HFA and VFE 
for both the data collected from the right eye t 
(49) = 0.82, P= .41 and left eye, t (49) = .06, 
P=0.94.  
 
The level of agreement was further assessed 
through Bland-Altman plots. Fig. 2 shows right 
eye data for the stroke group. Fig. 3 shows 
combined stroke and control group data from the 
right eye. The plots show that as more missed 
points are detected, the agreement between the 
two modalities reduces. The charts also 
demonstrate wide limits of agreement between 
both modalities. 
 
 
 
Fig. 2. Bland-Altman plots of unseen test 
points (%) between the HFA and VFE for the 
right eye of stroke groups 
The middle scored line represents the mean bias. The 
upper and lower scored lines represent the upper and 
lower 95% Limits of Agreement. N=50 
 
 
Fig. 3. Bland-Altman plots of unseen test 
points (%) between the HFA and VFE for the 
right eye of stroke and control groups 
combined 
The middle scored line represents the mean bias. The 
upper and lower scored lines represent the upper and 
lower 95% Limits of Agreement. N=100 
 
Descriptive statistics to accompany the 
agreement plots are provided in Table 2. 
 
3.3 Detecting an Abnormal Visual Field 
 
To establish if the VFE application could be used 
to detect the presence of an abnormal visual 
field, sensitivity and specificity values were 
calculated using Fisher’s exact test. Values 
relating to the applications ability as to detect an 
abnormal visual field are given in Table 3.  
 
3.4 Test Duration 
 
A comparison of test times between the HFA and 
VFE was performed with a paired samples t-test. 
In the stroke group HFA had a longer mean test 
time by 01:36 (mm:ss) (95% CI, 02:01 to 01:10) 
than VFE, t=7.491, p < .0005, effect size was 
large at d=1.0. In the control group VFE had the 
longer test time by 00:08 (mm:ss) (95% CI, 
00:01-00:16) than the HFA, t= 2.3, p<.020, effect 
size was small d=0. 3. The largest range for test 
time was for the HFA analyses of stroke patients 
(Fig. 4). 
 
3.5 Participant Feedback 
 
In the stroke group 88% of participants found the 
VFE test more comfortable to perform, and 22% 
indicated they would be interested in using the 
application to test their visual field at home. In 
addition, 64% of the stroke group found it easier 
to fixate on the central target with the VFE 
application. In the control group 58% found the 
VFE application the more comfortable, and 56% 
found it easier to hold steady fixation with the 
HFA.  
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Table 2. Descriptive statistics for Bland-Altman analysis  
 
  % of unseen test points identified 
Stroke group RE Normal group RE Combined groups RE 
Bias (mean) -2.39 -6.14 -4.17 
SD of Bias 19.21 7.36 14.55 
 Lower 95 % Limit of agreement -40.04 -20.58 -32.69 
Upper 95% Limit of agreement 35.26 8.298 24.33 
Coefficient of agreement 37.31 14.33 29.29 
Data collected for the right eye (RE) of the Stroke and Normal populations, and both populations together in a 
combined group 
 
Table 3. Sensitivity and specificity, and predictive values for detecting visual field loss with the 
VFE application 
 
 RE stroke group (95% CI) LE stroke group (95% CI) 
Sensitivity 0.89 (0.73-0.96) 0.85 (0.67 – 0.94) 
Specificity 0.76 (0.55-0.89) 0.77 (0.57- 0.90) 
+VE predictive value 0.83(0.66- 0.93) 0.82 (0.64 – 0.92) 
-VE predictive value 0.84 (0.62-0.94) 0.81 (0.6 – 0.92) 
P value <.001 <.001 
 
 
 
Fig. 4. Test durations for data gathered from the right eye for the stroke and control groups 
with both test types 
 
3.6 Discussion 
 
This study compared the VFE application to the 
HFA SITA Fast C30-2 programme in stroke 
survivors and in a control population. When 
assessing the agreement between the modalities 
a visual inspection of the Bland-Altman plots 
highlighted that when the magnitude of field loss 
was small there was good agreement between 
both measures. This suggests that the VFE can 
be a useful tool in ruling out diffuse dense visual 
field loss. However, there was a larger 
disagreement as the magnitude of field loss 
increased. 
 
When assessing the extent of visual field loss, 
there is a tendency for the VFE application to 
detect a higher proportion of unseen test points. 
The mean bias for the normal group was an 
overestimation of missed visual field test points 
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by 6% and 2% in the stroke population in 
comparison to the HFA ‘Gold Standard’. For the 
purpose of screening for stroke related visual 
field loss this figure may be of only limited clinical 
significance. 
 
However, for both the normative and stroke 
populations the upper and lower 95% Limits of 
Agreement are large and provide clinically 
ambiguous data, the results of the Bland-            
Altman analysis suggest the VFE is not an 
identical comparison to the HFA c30-2 reference 
test. 
 
In order to validate the tests usefulness as a 
screening tool in stroke patients, the VFE results 
were classified as normal or abnormal and 
results then compared to the HFA. This is 
possibly of most clinical significance in screening 
for visual field loss and an essential function of 
the confrontation method [28]. For the stroke 
group, sensitivity was high at 89% and 85% 
respectively for right and left eyes. Specificity 
was lower at 76% which fits with previous 
explanations that the VFE application is 
hypersensitive to field loss [29]. Positive and 
negative predictive values were also high at 0.83 
and 0.84. Cassidy [15] found the standard 
confrontation method to have 94% sensitivity for 
detection of visual field loss on patients admitted 
for stroke, however, this fell to 56% in 
subsequent weeks as the visual field improved. 
Studies on the confrontation method concluded 
its sensitivity and specificity depended on the 
type, density and cause of the visual field defect 
as well as the type of confrontation method used 
[28]. In Kerr’s study [28] the highest levels of 
sensitivity and specificity were 74% and 93% 
respectively on confrontation. 
 
Comparing the test duration times between the 
HFA SITA Fast c30-2 and the VFE demonstrated 
a longer test time when using the VFE in the 
normative group. Although the increased test 
duration was on average 8 seconds, this was not 
clinically significant. For the stroke population, 
which comprised patients with visual field loss, 
the VFE application was quicker by an average 
of 1 minute 36 seconds. Whilst the HFA c30-2 
algorithm rechecks test locations on multiple 
occasions at various light intensities, this is not 
true of the VFE which checks using the same 
stimulus intensity at every location. However the 
lesser test time of the VFE for stroke survivors 
may be of some clinical significance for initial 
assessments as stroke survivors are more prone 
to fatigue [30] which can impact on the reliability 
of visual field tests [31]. 
Qualitative results of the patient’s experience 
with the tests were interesting. In this study 88% 
of stroke survivors found the VFE test more 
comfortable to perform, relatively few patients 
(22%) were interested in evaluating their visual 
field at home using the VFE.  
 
The results suggest that the VFE is a promising 
screening tool for visual field assessment in 
stroke survivors but is not intended to replace 
standard perimetry. Further study should 
compare it to the visual fields to conformation 
method which is the main alternative used in 
bedside visual field assessments. Further study 
would include collection of longitudinal data 
make comparisons of the applications sensitivity 
and specificity over time and examine the 
repeatability of the test. Repeated testing with 
the application may have improved the overall 
accuracy of the assessment and shortened 
testing time, due to the known learning effects in 
visual field assessment [32]. It would also be 
beneficial to study a census of patients in the 
stroke unit, as the population studied here were 
preselected to have a likely visual problem, and 
the ability to attend the outpatient clinic. 
Assessments of visual neglect which can be 
confused with visual field loss were not controlled 
for as part of this study. Similarly, to the 
confrontation fields method the VFE application 
is a portable, quick and easy to use method of 
visual field assessment, which was well tolerated 
by patients. However, from experience the 
confrontation field method is a more rapid 
method of assessment, and it is easier to 
observe the patient’s fixation during the process. 
The VFE application has the additional 
advantages of producing electronic reports which 
can be added to patient records and may be 
delivered by all types staff with minimal training. 
 
4. CONCLUSION 
 
As a screening tool, the VFE application was 
quick and easy to administer, preferred by 
patients and demonstrated good sensitivity and 
specificity for detecting the presence of an 
abnormal visual field when compared to HFA. 
The VFE app had a similar test time in the 
normative group to the HFA and in the Stroke 
group was faster by 1 minute 36 seconds which 
has the potential to be clinically advantageous. 
There was a tendency for the VFE application to 
over-detect missed test points, which was more 
evident in the normative group. The application 
has several advantages over the confrontation 
method and could be a useful adjunct to the 
bedside vision assessment. It may bridge the 
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gap until patients are able to perform verified 
perimetry. 
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